ProCE Banner Activity


Beyond Barriers: Managed Care Approaches to Ensure Equitable and Timely Access to BCMA-Directed Therapy in Multiple Myeloma


On-demand webcast of expert faculty presentation on managed care approaches to multiple myeloma, including strategies for ensuring equitable access to care and review of BCMA-directed therapies.

Pharmacists: 1.50 contact hours (0.15 CEUs)

Released: April 24, 2024

Expiration: April 23, 2025



Rebecca Gonzalez

Rebecca Gonzalez, PharmD, BCOP

Blood and Marrow Transplant and Cellular Immunotherapy Clinical Pharmacist
Moffitt Cancer Center
Tampa, Florida

Melissa Pozotrigo

Melissa Pozotrigo, PharmD, BCOP

Senior Clinical Oncology Pharmacist
Atlanta, Georgia

Provided by

Provided by ProCE, LLC in partnership with Clinical Care Options, LLC

ProCE Banner


Supported by an educational grant from Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC


Clinical Care Options, LLC

ProCE Banner

Target Audience

The target audience for this activity is pharmacists, including managed care, specialty, and clinical pharmacists, who care for patients with multiple myeloma and pharmacy directors, chief pharmacy officers, and other stakeholders in pharmacy practice and managed care.

Program Learning Goal

The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Myelofibrosis.

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Assess the role of BCMA and BCMA-targeted therapies in R/R MM

  • Evaluate efficacy and safety evidence for BCMA-targeted therapies in patients with R/R MM and the impact of therapeutic choices in a managed care setting

  • Apply recommendations to identify and manage treatment-related AEs in patients treated with BCMA-targeted therapies for R/R MM

  • Integrate best practices in managed care with recent updates on BCMA-targeted therapies to optimize equitable access and informed formulary decisions for R/R MM patients


ProCE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Rebecca Gonzalez, PharmD, BCOP

Blood and Marrow Transplant and Cellular Immunotherapy Clinical Pharmacist
Moffitt Cancer Center
Tampa, Florida

Rebecca Gonzalez, PharmD, BCOP, has no relevant financial relationships to disclose.

Melissa Pozotrigo, PharmD, BCOP

Senior Clinical Oncology Pharmacist
Atlanta, Georgia

Melissa Pozotrigo, PharmD, BCOP, has no relevant financial relationships to disclose.

The planners and content peer reviewers from ProCE, LLC and Clinical Care Options, LLC do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.5 hours. To successfully complete this activity and receive credit, learners must follow these steps during the period from April 24, 2024, through April 23, 2025:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.


This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.



This activity is jointly provided by ProCE, LLC and Clinical Care Options, LLC. ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-24-004-H01-P has been assigned to this home study application-based activity. This activity is approved for 1.5 contact hours (0.15 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Completion of the evaluation and the post-test with a score of 65 or higher are required to receive CE credit. No partial credit will be given. Statements of completion will be issued online at, and proof of completion will be posted in NABP CPE Monitor profiles.